Immunotherapy Infuses New Hope Into Merkel Cell Carcinoma Care
October 25, 2017
On October 19th, 2017, Danielle Bucco of OncLive released an article pertaining to the advantages of treating Merkel cell carcinoma with immunotherapy. Historically, chemotherapy has been used as the first line of treatment. However, recent statistics highlight the difference in progression-free survival rates between chemotherapy and immunotherapy. This, among other factors, has largely contributed towards the push against treating MCC with chemotherapy. In fact, in the recent 2018 guidelines, immunotherapy regimens have displaced chemotherapy. For more information, view the article here, or the download the article below.
Click to downloadThe authoritative source on Merkel cell carcinoma.
Last updated:
July 11, 2023
About the Disease
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
Testing & Diagnosis
Created in partnership with:
Seattle Multidisciplinary MCC Team, University of Washington MCC Research, Fred Hutchinson Cancer Research Center, and the Seattle Cancer Care Alliance/Skin Cancer